Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

34 recalls, newest first

Class III · Low risk

buPROPion Hydrochloride Extended-Release Tablet

Presence Of Foreign Substance: Customer complaint for the presence of dark, gritty substance found within the bottle which was determined to be activated carbon from the desiccant canister inside the bottle.

Terminated Particulate / foreign matter Sun Pharmaceutical Industries INC NDC 47335-738-86 D-0858-2022
Class III · Low risk

buPROPion Hydrochloride Extended-Release Tablet

Presence Of Foreign Substance: Customer complaint for the presence of dark, gritty substance found within the bottle which was determined to be activated carbon from the desiccant canister inside the bottle.

Terminated Particulate / foreign matter Sun Pharmaceutical Industries INC D-0857-2022
Class II · Moderate risk

Glycopyrrolate Tablets

Presence of Foreign Substance: Complaint for pieces of glass discovered in a sealed bottle which came from equipment within the packaging room.

Terminated Particulate / foreign matter Aurolife Pharma, LLC NDC 13107-014-01 D-0736-2022
Class I · High risk

Sodium Acetate Injection

Presence of particulate matter: particulates composed of carbon and oxygen with varying amounts of iron and trace amounts of sodium, silicon, chromium, aluminum and cellulose.

Terminated Particulate / foreign matter Fresenius Kabi USA, LLC NDC 63323-032-00 D-0750-2022
Class II · Moderate risk

Chlorthalidone Tablets USP 25 mg

Foreign Matter identified as stainless steel microscopic wear particles mixed with punch lubricant oil and silicone particles from the dust cup

Terminated Particulate / foreign matter Sun Pharmaceutical Industries INC NDC 57664-648-88 D-0578-2022

Recalls by year